Critical role of CD44 in hepatotoxin-mediated liver injury

Kiminori Kimura1, Masahito Nagaki, Kazuhiro Kakimi

  • 1Department of Immunotherapeutics (Medinet), Graduate School of Medicine, The University of Tokyo, 1-3-7 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. kkimura@m.u-tokyo.ac.jp

Journal of Hepatology
|April 9, 2008
PubMed
Abstract

Insights

Targeting CD44 in inflammatory liver diseases shows mixed results. While it suppresses early inflammation, it can worsen liver injury later by increasing hepatocyte apoptosis, suggesting caution is needed.

Area of Science:

  • Immunology
  • Hepatology
  • Pharmacology

Background:

  • Blocking adhesion molecules is a potential therapeutic strategy for inflammatory diseases.
  • The efficacy of targeting adhesion molecules like CD44 in liver inflammation remains unclear.

Purpose of the Study:

  • To investigate the role of CD44 in controlling liver injury induced by carbon tetrachloride (CCl4).
  • To assess the therapeutic potential of CD44 inhibition in inflammatory liver conditions.

Main Methods:

  • Utilized CD44-deficient mice to model CCl4-induced liver injury.
  • Analyzed inflammatory cell infiltration, cytokine production, and hepatocyte apoptosis.
  • Investigated the involvement of NF-kappaB, macrophages, MIP-2, and TNF-alpha.

Main Results:

  • CD44 deficiency initially suppressed liver inflammation and cytokine production within 6 hours post-CCl4 injection.
  • However, CD44 deficiency led to severe liver inflammation and increased hepatocyte apoptosis after 12 hours.
  • Hepatocyte apoptosis was linked to reduced NF-kappaB activity and macrophage involvement, with MIP-2 and TNF-alpha playing a role.

Conclusions:

  • Targeting CD44 for inflammatory liver diseases requires careful consideration of the liver's immune system.
  • The dual role of CD44 in early suppression and late exacerbation of liver injury necessitates cautious therapeutic application.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...